TNM staging with FDG-PET/CT in patients with primary head and neck cancer

[1]  David W. Townsend,et al.  Positon emission tomography: basic science and clinical practice , 2008 .

[2]  M. Mack,et al.  Head and Neck Lesions , 2008 .

[3]  L. Peters,et al.  Clinical impact of, and prognostic stratification by, F‐18 FDG PET/CT in head and neck mucosal squamous cell carcinoma , 2007, Head & neck.

[4]  W. Roa,et al.  Iterative threshold segmentation for PET target volume delineation. , 2007, Medical physics.

[5]  Sasa Mutic,et al.  18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  A. Colevas.  Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  F. Caponigro,et al.  Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents , 2006, Current opinion in oncology.

[8]  Y. Erdi,et al.  18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  S. Zwas,et al.  PET/CT in the evaluation of patients with squamous cell cancer of the head and neck. , 2006, International journal of oral and maxillofacial surgery.

[10]  G. Stoffels,et al.  18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  R. Wahl,et al.  The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[12]  G. Goerres,et al.  Bone invasion in patients with oral cavity cancer: comparison of conventional CT with PET/CT and SPECT/CT. , 2005, Radiology.

[13]  Martin A Lodge,et al.  Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer , 2005, Nuclear medicine communications.

[14]  C. Snyderman,et al.  Head and neck malignancy: is PET/CT more accurate than PET or CT alone? , 2005, Radiology.

[15]  Thomas Beyer,et al.  On the use of positioning aids to reduce misregistration in the head and neck in whole-body PET/CT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  Yuji Nakamoto,et al.  Normal FDG distribution patterns in the head and neck: PET/CT evaluation. , 2005, Radiology.

[17]  J. Debatin,et al.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience. , 2005, Radiology.

[18]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[19]  Jean-François Daisne,et al.  Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.

[20]  H. Schöder,et al.  Positron emission imaging of head and neck cancer, including thyroid carcinoma. , 2004, Seminars in nuclear medicine.

[21]  Thomas Beyer,et al.  Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. , 2004, Radiology.

[22]  James A. Scott,et al.  Positron Emission Tomography: Basic Science and Clinical Practice , 2004 .

[23]  J. Debatin,et al.  Effect of oral contrast agents on computed tomography-based positron emission tomography attenuation correction in dual-modality positron emission tomography/computed tomography imaging. , 2003, Investigative radiology.

[24]  W. Wong,et al.  The impact of FDG PET on the management of occult primary head and neck tumours. , 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

[25]  E. Vokes,et al.  Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Thomas Beyer,et al.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Thomas F Hany,et al.  Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. , 2002, AJR. American journal of roentgenology.

[28]  Cristián Zegers Ariztía,et al.  Manual , 2002 .

[29]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[30]  M. Schwaiger,et al.  Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. , 1999, Archives of otolaryngology--head & neck surgery.

[31]  D. Yousem,et al.  Head and neck lesions. Radiologic-pathologic correlations. , 1998, Radiologic clinics of North America.

[32]  G. Hör,et al.  Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer , 1998, European Journal of Nuclear Medicine.

[33]  M P Sandler,et al.  Evaluation of benign vs malignant hepatic lesions with positron emission tomography. , 1998, Archives of surgery.

[34]  T Tango,et al.  Equivalence test and confidence interval for the difference in proportions for the paired-sample design. , 1997, Statistics in medicine.

[35]  D. Yousem,et al.  Radiologic-Pathologic Correlations , 1998 .

[36]  H. Baddeley,et al.  A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. , 1997, Clinical otolaryngology and allied sciences.

[37]  D J Hawkes,et al.  Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. , 1996, American journal of surgery.

[38]  R. Wahl,et al.  Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. , 1996, Radiology.

[39]  R. Felix,et al.  Spiral-CT von zervikalen Lymphknotenvergrößerungen , 1994 .

[40]  N. Hosten,et al.  Enlarged cervical lymph nodes at helical CT. , 1994, Radiology.

[41]  N. Hosten,et al.  [The spiral CT of cervical lymph node enlargements. The initial clinical results]. , 1994, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.